Farida Rendrayani

Mrs. Farida Rendrayani

Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Jawa Barat, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
SASofa Dewi Alfian
Sofa Dewi Alfian
WWWawan Wahyudin
Wawan Wahyudin
IPIrma Melyani Puspitasari
Irma Melyani Puspitasari
Understanding pharmacists’ knowledge, attitudes, and practices (KAP) and their perceptions of challenges, barriers, and facilitators towards medication therapy management (MTM) provision are vital in informing the design and implementation of successful service delivery. Thus, this review examined pharmacists’ knowledge, attitudes, and practices, and their perceived challenges, barriers, and facilitators to MTM services provision, globally. A systematic search was conducted on 1–31 August 2022 to identify relevant studies on PubMed and EBSCO, supplemented with a bibliographic and a particular hand search. We focused on original research in quantitative survey form with the key concepts of “medication therapy management”, “pharmacists”, and “knowledge, attitude, practice”. We assessed the reporting quality using the Checklist for Reporting of Survey Studies (CROSS). Results are reported narratively and according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. From 237 articles identified, 17 studies met the eligibility criteria. Of the included studies, five reported that pharmacists had a considerable level of knowledge, seven suggested a positive attitude among pharmacists, and five revealed that pharmacists had been practicing some MTM elements. Factors associated with pharmacists’ KAP may include age, educational degree, additional qualification, income, years of practice, practice setting, and experience in patient care service. The challenges toward MTM provision were related to the pharmacist-patient and pharmacist-physician relationship. Insufficient time, staff, compensation, and training were the barriers, while patients’ willingness to participate and educational background were the facilitators of MTM provision. These findings of studies on KAP could help develop an MTM program and design an intervention to improve program effectiveness. Further research focusing on other quantitative and qualitative studies of KAP is needed to obtain a comprehensive approach to MTM provision.

1 May 2024 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
SASofa Dewi Alfian
Sofa Dewi Alfian
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
QKQisty A. Khoiry
Qisty A. Khoiry
MPMochammad A.A. Pratama
Mochammad A.A. Pratama
MGMeliana Griselda
Meliana Griselda
RARizky Abdulah
Rizky Abdulah
Pharmacists play a vital role in counseling customers on proper medication disposal, yet their consistency in providing such information is often lacking. This study aimed to assess pharmacists’ awareness of appropriate disposal practices for unused and expired household medications. Additional objectives included evaluating whether pharmacists offer disposal information during counseling, measuring their willingness to receive medication waste from the public, and identifying associated factors. A national cross-sectional online survey employing convenience sampling was conducted among pharmacists working in hospitals, pharmacies, clinics, or community health centers (CHCs) in Indonesia, using a validated questionnaire to assess awareness, information provision, and willingness to receive medications for disposal. Binary logistic regression, with 95% confidence intervals (CI) and odds ratios (OR), explored potential associations between factors and outcomes. This study involved 1,596 pharmacists across 37 Indonesian provinces. Most pharmacists were women (80.4 %), aged 31–40 years (49.3 %), with a pharmacist professional background (93.8 %), working in CHCs (41.2 %), and practicing for 1–5 years (51.0 %). More than half were unaware of guidelines for returning medications to health facilities. While 69.9 % never counseled customers on disposal practices, 64.9 % expressed willingness to receive unused and expired medication from the public. Pharmacists practicing for at least six years were more likely to provide disposal information during counseling (OR: 2.54; 95 % CI: 1.44–4.47). Conversely, those in clinics (OR: 2.16; 95 % CI: 1.29–3.62), CHCs (OR: 2.07; 95 % CI: 1.45–2.95), or hospitals (OR: 2.00; 95 % CI: 1.27–3.14) were more likely to be unwilling to receive expired and unused household medication. The study reveals that most pharmacists, particularly those with limited practice duration, lacked awareness regarding the importance of proper medication disposal and did not provide counseling on appropriate medication disposal to patients. To address this issue, there is a pressing need for intensified education intensified education at the undergraduate level, continuous training for pharmacists, and a clear policy and practical guidelines, particularly targeting pharmacists in clinics, CHCs, and hospitals, to facilitate the acceptance of unused and expired household medications.

13 September 2022 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
AUAuliasari M Utami
Auliasari M Utami
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
QKQisty A Khoiry
Qisty A Khoiry
FAFitri Alfiani
Fitri Alfiani
AKArif S W Kusuma
Arif S W Kusuma
ASAuliya Abdurrohim Suwantika
Auliya Abdurrohim Suwantika
Background: WHO reported that 5.5 million people died in the world because of COVID-19. One of the efforts to mitigate the pandemic is administrating the vaccines globally. Objective: The objective of this study was to review cost-effectiveness analysis of COVID-19 vaccination in low- and middle-income countries (LMICs). Methods: We searched PubMed and EBSCO for the eligible studies with inclusion criteria using cost-effectiveness analysis, free full text, low-middle-income countries, and the publication date since the last year. Four reviewers conducted the review independently. Results: The review identified four articles meeting the eligibility criteria. The settings were LMICs. Different perspectives and economic modelling used by the countries confirmed a similar result. They all explained that vaccination could prevent the infection spread and mortality caused by COVID-19 and showed high cost-effectiveness values. Conclusion: Administering COVID-19 vaccines was cost-effective and even cost-saving. The studies found that vaccination was more cost-effective in reducing the spread of the COVID-19 virus and the mortality it caused than no vaccination.

1 October 2024 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
PDF file
ILIrma Rahayu Latarissa
Irma Rahayu Latarissa
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
GIGhina Nadhifah Iftinan
Ghina Nadhifah Iftinan
CSCecep Suhandi
Cecep Suhandi
AMAnna Meiliana
Anna Meiliana
KLKeri Lestari
Keri Lestari
The COVID-19 pandemic is prompting extensive investigation into potential treatments, including the use of corticosteroids to manage inflammation and mitigate severe disease outcomes. Therefore, this systematic review aimed to evaluate the efficacy of oral/intravenous corticosteroids in the management of COVID-19. A comprehensive search was conducted across major scientific databases such as MEDLINE, Scopus, and Cochrane for relevant studies published from 2019– 2024. The inclusion criteria included studies investigating the use of oral/intravenous corticosteroids in COVID-19 patients > 18 years with a randomized placebo-controlled trial method. Non-placebo-controlled studies, studies using combined treatments with other drugs, as well as protocol articles, conference proceedings, review articles, and non-English studies were excluded. A narrative synthesis approach was adopted given the significant methodological diversity. The results showed that a total of 12 studies met the inclusion criteria covering the use of three drugs, including dexamethasone (three), hydrocortisone (two), and methylprednisolone (seven). The outcome parameters used for each study were different. Among the total 12 studies, five showed insignificant results for hydrocortisone (two) and methylprednisolone (three), while others reported significant results. This systematic review suggested that oral/intravenous corticosteroids might confer clinical benefits in the management of COVID-19, particularly in reducing mortality and severe disease outcomes. However, further investigation was needed to establish standardized protocols regarding dosage, duration, and safety considerations to optimize efficacy and minimize potential adverse effects.

22 May 2024 in Dharmakarya
Verified
Journal Article
Open access
PDF file
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
NZNeily Zakiyah
Neily Zakiyah
MBMelisa Intan Barliana
Melisa Intan Barliana
IPIrma Melyani Puspitasari
Irma Melyani Puspitasari
EDUKASI KESEHATAN JIWA PADA IBU-IBU DI POSYANDU DESA KUTAMANDIRI KECAMATAN TANJUNGSARI KABUPATEN SUMEDANG

30 September 2025 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
AAAni Anggriani
Ani Anggriani
EHEli Halimah
Eli Halimah
SMSiti Saidah Mutmainah
Siti Saidah Mutmainah
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
RSRano Sinuraya
Rano Sinuraya
IPIrma Melyani Puspitasari
Irma Melyani Puspitasari
Introduction: Clinical pharmacists play a crucial role in identifying drug-related problems (DRPs) during the assessment of chemotherapy regimens. In hospitals, this assessment involves identification, intervention, and resolution. However, since the process is largely conducted manually, it becomes time-consuming and inefficient. This study aims to explore the perspectives of clinical pharmacists regarding the current chemotherapy regimen DRPs assessment process and the need for an application (app) to improve and streamline this assessment. Methods: A focus group discussion (FGD) was conducted with 11 clinical pharmacists responsible for reviewing chemotherapy regimens at a hospital in Indonesia. The discussions were recorded, transcribed, and analyzed using NVivo 15.0.0. Results: The current DRPs assessment is time-consuming due to redundant documentation, requiring daily data entry and reentry for monthly reports. Issues include long processing times and potential body surface area (BSA) and dose calculation errors. Clinical pharmacists expressed the need for a DRPs app to streamline workflow and reduce errors. They emphasized clear, readable fonts, a purple color scheme, and a comprehensive drug database aligned with hospital, Ministry of Health, and national formulary standards. The app should be user-friendly and accessible on both computers and smartphones. Conclusions: This study highlights that the current manual handwriting-based DRPs assessment process for chemotherapy regimens is inefficient and requires repeated documentation. Clinical pharmacists strongly advocate for the development of an app that streamlines the assessment of DRPs, facilitates accurate and timely reporting of medication errors, and enhances overall efficiency in chemotherapy regimen evaluations.